Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
LANCET. Bd. 403. H. 10441. 2024 S. 2293-2306
Erscheinungsjahr: 2024
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Dreyling, Martin (Autor)
Doorduijn, Jeanette (Autor)
Gine, Eva (Autor)
Jerkeman, Mats (Autor)
Walewski, Jan (Autor)
Hutchings, Martin (Autor)
Mey, Ulrich (Autor)
Riise, Jon (Autor)
Trneny, Marek (Autor)
Vergote, Vibeke (Autor)
Shpilberg, Ofer (Autor)
da Silva, Maria Gomes (Autor)
Leppa, Sirpa (Autor)
Jiang, Linmiao (Autor)
Stilgenbauer, Stephan (Autor)
Kerkhoff, Andrea (Autor)
Jachimowicz, Ron (Autor)
Celli, Melania (Autor)
Hess, Georg (Autor)
Arcaini, Luca (Autor)
Visco, Carlo (Autor)
van Meerten, Tom (Autor)
Wirths, Stefan (Autor)
Zinzani, Pier Luigi (Autor)
Novak, Urban (Autor)
Herhaus, Peter (Autor)
Benedetti, Fabio (Autor)
Sonnevi, Kristina (Autor)
Hanoun, Christine (Autor)
Haenel, Matthias (Autor)
Dierlamm, Judith (Autor)
Pott, Christiane (Autor)
Klapper, Wolfram (Autor)
Goezel, Doendue (Autor)
Schmidt, Christian (Autor)
Unterhalt, Michael (Autor)
Ladetto, Marco (Autor)
Hoster, Eva (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
